$485M raised across 2 disclosed Series E deals.
Last updated · Jun 13, 2026, 8:22 PM UTC · RSS
| Date | Company | Amount | Round | Sector | Country | Lead investors |
|---|---|---|---|---|---|---|
| Jun 09, 26 | GT Medical Technologies GT Medical Technologies develops innovative treatments for brain tumor patients, focusing on improving survival outcomes and quality of life. Their flagship product, GammaTile therapy, delivers immediate targeted radiation at the tumor site during surgery, aiming to reduce tumor regrowth and limit exposure to healthy brain tissue. | $100.0M | Series E | Health | United States | Viking Global Investors, MVM Partners, Gilde Healthcare+3 |
| May 22, 26 | Vestwell Vestwell is a modern WealthTech platform designed to help Americans save for retirement, higher education, and emergencies. It serves employers, financial advisors, payroll providers, and government agencies, overseeing upwards of $50 billion in assets. The company recently raised $385 million in a Series E funding round, doubling its valuation since its previous funding round. | $385.0M | Series E | Fintech | United States | Blue Owl Capital, Sixth Street Growth, Neuberger Berman+5 |
Filtered to your country and sector. One email per week.